Pulmonary hypertension chest x ray: Difference between revisions
No edit summary |
|||
Line 7: | Line 7: | ||
==Chest X Ray== | ==Chest X Ray== | ||
Findings of PH on chest X-ray include:<ref name="pmid26552229">{{cite journal |vauthors=Korobkova IZ, Lazutkina VK, Nizovtsova LA, Riden TV |title=[Radiographic assessment of pulmonary hypertension: Methodical aspects] |language=Russian |journal=Vestn Rentgenol Radiol |volume= |issue=4 |pages=45–53 |date=2015 |pmid=26552229 |doi= |url=}}</ref><ref name="pmid24311231">{{cite journal |vauthors=Pienn M, Kovacs G, Tscherner M, Avian A, Johnson TR, Kullnig P, Stollberger R, Olschewski A, Olschewski H, Bálint Z |title=Non-invasive determination of pulmonary hypertension with dynamic contrast-enhanced computed tomography: a pilot study |journal=Eur Radiol |volume=24 |issue=3 |pages=668–76 |date=March 2014 |pmid=24311231 |doi=10.1007/s00330-013-3067-8 |url=}}</ref> | Findings of PH on chest X-ray include:<ref name="pmid26552229">{{cite journal |vauthors=Korobkova IZ, Lazutkina VK, Nizovtsova LA, Riden TV |title=[Radiographic assessment of pulmonary hypertension: Methodical aspects] |language=Russian |journal=Vestn Rentgenol Radiol |volume= |issue=4 |pages=45–53 |date=2015 |pmid=26552229 |doi= |url=}}</ref><ref name="pmid24311231">{{cite journal |vauthors=Pienn M, Kovacs G, Tscherner M, Avian A, Johnson TR, Kullnig P, Stollberger R, Olschewski A, Olschewski H, Bálint Z |title=Non-invasive determination of pulmonary hypertension with dynamic contrast-enhanced computed tomography: a pilot study |journal=Eur Radiol |volume=24 |issue=3 |pages=668–76 |date=March 2014 |pmid=24311231 |doi=10.1007/s00330-013-3067-8 |url=}}</ref><ref name="pmid23912192">{{cite journal |vauthors=Cordova FC, D'Alonzo G |title=Sarcoidosis-associated pulmonary hypertension |journal=Curr Opin Pulm Med |volume=19 |issue=5 |pages=531–7 |date=September 2013 |pmid=23912192 |doi=10.1097/MCP.0b013e328363f4a3 |url=}}</ref> | ||
* [[Hilar]] pulmonary arterial dilation | * [[Hilar]] pulmonary arterial dilation | ||
* Loss of peripheral blood vessel markings | * Loss of peripheral blood vessel markings |
Revision as of 17:06, 6 March 2018
Pulmonary Hypertension Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pulmonary hypertension chest x ray On the Web |
American Roentgen Ray Society Images of Pulmonary hypertension chest x ray |
Risk calculators and risk factors for Pulmonary hypertension chest x ray |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Richard Channick, M.D.; Assistant Editor(s)-in-Chief: Ralph Matar.
Overview
Chest X-ray is abnormal in the majority of patients with pulmonary hypertension (PH); however, there is no correlation between the severity of PH and the findings on chest X-ray. Findings of PH on chest X-ray include pulmonary artery dilatation and right sided enlargement of the heart. Chest X-ray allows the exclusion of left heart disease and lung disease that can lead to group 2 and group 3 PH, respectively.
Chest X Ray
Findings of PH on chest X-ray include:[1][2][3]
- Hilar pulmonary arterial dilation
- Loss of peripheral blood vessel markings
- Enlarged right atrium and right ventricle in advanced diseases
Shown below are chest X-ray images of patients with PH.
-
This is a posteroanterior radiograph revealing enlarged pulmonary arteries in a patient with atrial septal defect.
-
References
- ↑ Korobkova IZ, Lazutkina VK, Nizovtsova LA, Riden TV (2015). "[Radiographic assessment of pulmonary hypertension: Methodical aspects]". Vestn Rentgenol Radiol (in Russian) (4): 45–53. PMID 26552229.
- ↑ Pienn M, Kovacs G, Tscherner M, Avian A, Johnson TR, Kullnig P, Stollberger R, Olschewski A, Olschewski H, Bálint Z (March 2014). "Non-invasive determination of pulmonary hypertension with dynamic contrast-enhanced computed tomography: a pilot study". Eur Radiol. 24 (3): 668–76. doi:10.1007/s00330-013-3067-8. PMID 24311231.
- ↑ Cordova FC, D'Alonzo G (September 2013). "Sarcoidosis-associated pulmonary hypertension". Curr Opin Pulm Med. 19 (5): 531–7. doi:10.1097/MCP.0b013e328363f4a3. PMID 23912192.